PLASMA LEVELS OF ACTIVE INGREDIENTS AFTER SINGLE AND REPEATED ADMINISTRATION OF A NEW ORAL CONTRACEPTIVE CONTAINING 2 MG OF CYPROTERONE ACETATE AND 50 μg OF ETHINYL ESTRADIOL (DIANE®) TO FIVE YOUNG WOMEN